Literature DB >> 10891335

G6PD deficient cells and the bioreduction of disulfides: effects of DHEA, GSH depletion and phenylarsine oxide.

J E Biaglow1, I S Ayene, C J Koch, J Donahue, T D Stamato, S W Tuttle.   

Abstract

We used Glucose 6 phosphate dehydrogenase (G6PD) minus cells (89 cells) and G6PD containing cells (K1) to understand the mechanisms of bioreduction of disulfide and the redox regulation of protein and non protein thiols in mammalian cells. The 89 cells reduce hydroxyethyldisulfide (HEDS) to mercaptoethanol (ME) at a slower rate than K1 cells. HEDS reduction results in loss of nonprotein thiols (NPSH) and a decrease in protein thiols (PSH) in 89 cells. The effects are less dramatic with K1 cells. However, the loss of NPSH and PSH in K1 cells are increased in the absence of glucose. Glutathione-depletion with L-BSO partially blocks HEDS reduction in K1 and 89 cells. Treatment with the vicinal thiol reagent phenyl arsenic oxide (PAO) blocks reduction of HEDS in both cells. Surprisingly, dehydroepiandrosterone (DHEA), a known inhibitor of G6PD, inhibits the growth and blocks the reduction of HEDS both in 89 and K1 cells suggesting that its mechanism for inhibition of growth is not G6PD related. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10891335     DOI: 10.1006/bbrc.2000.3024

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction.

Authors:  David R Wise; Ralph J DeBerardinis; Anthony Mancuso; Nabil Sayed; Xiao-Yong Zhang; Harla K Pfeiffer; Ilana Nissim; Evgueni Daikhin; Marc Yudkoff; Steven B McMahon; Craig B Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-24       Impact factor: 11.205

2.  Hydroxyethyl disulfide as an efficient metabolic assay for cell viability in vitro.

Authors:  Jie Li; Donglan Zhang; Kathleen M Ward; George C Prendergast; Iraimoudi S Ayene
Journal:  Toxicol In Vitro       Date:  2012-01-31       Impact factor: 3.500

3.  Interactions of androgens, green tea catechins and the antiandrogen flutamide with the external glucose-binding site of the human erythrocyte glucose transporter GLUT1.

Authors:  Richard J Naftalin; Iram Afzal; Philip Cunningham; Mansur Halai; Clare Ross; Naguib Salleh; Stuart R Milligan
Journal:  Br J Pharmacol       Date:  2003-08-26       Impact factor: 8.739

Review 4.  Impact of glucose-6-phosphate dehydrogenase deficiency on the pathophysiology of cardiovascular disease.

Authors:  Peter A Hecker; Jane A Leopold; Sachin A Gupte; Fabio A Recchia; William C Stanley
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-12-15       Impact factor: 4.733

5.  A bioactive probe of the oxidative pentose phosphate cycle: novel strategy to reverse radioresistance in glucose deprived human colon cancer cells.

Authors:  Jie Li; Kathleen M Ward; Donglan Zhang; Eswarkumar Dayanandam; Albert S Denittis; George C Prendergast; Iraimoudi S Ayene
Journal:  Toxicol In Vitro       Date:  2012-08-16       Impact factor: 3.500

6.  A bioactive probe for glutathione-dependent antioxidant capacity in breast cancer patients: implications in measuring biological effects of arsenic compounds.

Authors:  Jie Li; Donglan Zhang; Pearl A Jefferson; Kathleen M Ward; Iraimoudi S Ayene
Journal:  J Pharmacol Toxicol Methods       Date:  2013-10-20       Impact factor: 1.950

Review 7.  Emerging roles of Myc in stem cell biology and novel tumor therapies.

Authors:  Go J Yoshida
Journal:  J Exp Clin Cancer Res       Date:  2018-07-27

8.  Antimetabolite TTL-315 selectively kills glucose-deprived cancer cells and enhances responses to cytotoxic chemotherapy in preclinical models of cancer.

Authors:  James DuHadaway; George C Prendergast
Journal:  Oncotarget       Date:  2016-02-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.